Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Outdated perceptions and practices fuelling mental health crisis, new Economist…
International analysis of mental health provision in eight G20 countries reveals stigma, a shortage of mental health professionals and inconsistent availability and quality of care are creating barriers to vital mental health care servicesNew research highlights global and country-level insights into where action is needed alongside recommendations for measures aimed at addressing these challenges London, Tue, 05/28/2024 - Findings from a new Economist Impact health care study...
Nasdaq GlobeNewswire
28/05/2024
Insmed Announces Positive Topline Results from Landmark ASPEN Study of…
—Brensocatib Well-Tolerated at Both Dosage Strengths— —Brensocatib Well-Tolerated at Both Dosage Strengths— —Results fromASPENValidate DPP1 Inhibition as New Mechanism of Action with Potential to Address Range of Neutrophil-Mediated Diseases— —Insmed Plans to Advance Quickly Toward U.S. Regulatory Filing, with Anticipated U.S. Launch in Mid-2025, Pending Approval— —Insmed to Host Investor Call at8:00 am ET on Tuesday, May 28, 2024— BRIDGEWATER, N.J.,May 28, 2024...
PR Newswire
28/05/2024
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, May28, 2024(GLOBE NEWSWIRE) --Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences:Jefferies Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings on June 5-6 and a...
Nasdaq GlobeNewswire
28/05/2024
Urteste has successfully developed a prototype urine-based diagnostic test for…
28 MAY 2024 PRESS RELEASE Urteste has successfully developed a prototype urine-baseddiagnostictestfordetecting braintumoursGdańsk,Poland–28MAY2024,UrtesteS.A.(WarsawStockExchange:URT)biotechnologycompany specialising in the development of breakthrough technology to detect cancer from urinesampleshasdevelopedaprototypeIVDtestfordetectingbraintumours.Urtestenowhasapipelineof 12 prototype diagnostic tests for the...
Nasdaq GlobeNewswire
28/05/2024
Medical Device Packaging Market worth $54.1 billion by 2029 - Exclusive Report…
Browse in-depth TOC on "Medical Device Packaging Market". Browse in-depth TOC on "Medical Device Packaging Market". 485 – Tables 59 – Figures337– Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54155604 "Plastic is projected to be the fastest-growing segment in the medical device packaging market." Plastic is the fastest-rising segment for the medical device packaging market from 2024 to 2029, in terms of value. This is because…
PR Newswire
28/05/2024
Spineart Receives 510(k) Clearance for SCARLET® AC-Ti Anterior Cervical Cage
The SCARLET® AC-Ti cervical cage utilizes Spineart's proprietary Ti-LIFE technology1. Ti-LIFE technology, a proprietary additive manufacturing process, has a porous structure that closely mimics the trabecular bone structure. The SCARLET® AC-Ti cervical cage utilizes Spineart's proprietary Ti-LIFE technology 1. Ti-LIFE technology, a proprietary additive manufacturing process, has a porous structure that closely mimics the trabecular bone structure. "This approval underscores our…
PR Newswire
28/05/2024
Binge Eating Disorder Market to Accelerate Substantially During the Study Period…
Key Takeaways from the Binge Eating Disorder Market Report Key Takeaways from the Binge Eating Disorder Market Report Discover which therapies are expected to grab the major binge eating disorder market share @Binge Eating Disorder Market Report Binge Eating Disorder Overview Binge eating disorder is a serious mental health condition characterized by recurrent episodes of consuming large quantities of food in a short period while feeling a loss of control over eating behavior...
PR Newswire
28/05/2024
Robotic Radiotherapy Market Worth USD 2.9 Billion by 2031 at 12.0% CAGR- Latest…
Request for Free Sample Report: https://www.insightaceanalytic.com/request-sample/2501 Request for Free Sample Report: https://www.insightaceanalytic.com/request-sample/2501 Robotic radiotherapy is an advanced method of delivering radiation treatment to cancer patients using highly sophisticated robotic technology. This technique allows extremely precise targeting of radiation doses to the tumor, minimizing damage to the surrounding healthy tissues. Robotic radiotherapy is especially...
PR Newswire
28/05/2024
High-performance Computing for Life Sciences Market Expected to Grow at a CAGR…
Get Free PDF Report Brochure: https://www.insightaceanalytic.com/report/high-performance-computing-for-life-sciences-market/2497 Get Free PDF Report Brochure: https://www.insightaceanalytic.com/report/high-performance-computing-for-life-sciences-market/2497 The high-performance computing (HPC) sector has emerged as a vital component in advancing life sciences research and applications, offering unprecedented computational power and capabilities to tackle complex biological and medical...
PR Newswire
28/05/2024
TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM…
TVM Capital Healthcare identifies unmet healthcare needs and invests in entrepreneurial companies that create lasting impact in their local communities while delivering strong returns to investors. The firm has built a solid reputation as the first international fund manager investing in and operating major healthcare companies in the Kingdom. It also invests in healthcare growth deals in Europe and the U.S. to support these companies' expansion plans for Saudi Arabia and the wider GCC. With…
PR Newswire
28/05/2024
Tattoo Removal Market to Reach $4.0 Billion, Globally, by 2035 at 19.1% CAGR…
Request Sample of the Report on Tattoo Removal Market Forecast 2035- https://www.alliedmarketresearch.com/request-sample/3537 Request Sample of the Report on Tattoo Removal Market Forecast 2035-https://www.alliedmarketresearch.com/request-sample/3537 Prime determinants of growth Growing advancements in tattoo removal technologies and presence of key players are the factors that drive the growth of the global tattoo removal market. However, high cost of tattoo removal procedures is...
PR Newswire
28/05/2024
Resolution Therapeutics to Participate in the Jefferies Global Healthcare…
View original content:https://www.prnewswire.co.uk/news-releases/resolution-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-302155382.html View original content: https://www.prnewswire.co.uk/news-releases/resolution-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-302155382.html
PR Newswire
28/05/2024
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in…
This statement is made by the Board of Directors (the "Board") of Calliditas Therapeutics AB (publ) ("Calliditas" or the "Company") pursuant to section II.19 of the Nasdaq Stockholm takeover rules ("Section II.19") and Regulation 14D under the Securities Exchange Act of 1934, as amended (together with Section II.19, the "Takeover Rules"). This statement is made by the Board of Directors (the " Board ") of Calliditas Therapeutics AB…
PR Newswire
28/05/2024
Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to…
Transformative Healthcare Across Continents Transformative Healthcare Across Continents The partnership's mission extends beyond improving patient care across Eurasia; it ambitiously targets expansion intoAfricaand the Arabian Peninsula, withIstanbulpositioned as the central hub. Moreover, this strategic alignment promises to bridge continents with top-tier healthcare solutions, enhancing access to advanced healthcare diagnostics. "We are thrilled to collaborate with Acıbadem...
PR Newswire
28/05/2024
Description of the regulatory framework of the share repurchase program proposed…
PARIS, FRANCE, 28 May 2024 - In accordance with the provisions of Article L.22-10-62 et seq. of the French Commercial Code, the European Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014, the Delegated Regulation No 2016/1052 of 8 March 2016, and the General Regulation of the FrenchAutorité des Marchés Financiers(AMF), the present description aims to describe the objectives and characteristics of the repurchase by the Company of its own shares,...
Nasdaq GlobeNewswire
28/05/2024
Santhera Publishes Agenda for its Annual General Meeting
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland.The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera's website at...
Nasdaq GlobeNewswire
28/05/2024
Santhera Publishes Annual Report 2023
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2023 with fully audited results for the year ended December 31, 2023.Santhera's Annual Report 2023 provides comprehensive and detailed information on the Company, its strategy, business, financial performance, governance and compensation in 2023, and confirms the preliminary unaudited 2023 annual results which were published...
Nasdaq GlobeNewswire
28/05/2024
Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024
The publication will be followed by an investor conference call and webcast on Wednesday, May 29, 2024 at 8:00 AM ET / 2:00 PM CET. The call will include the Company's first quarter results and an update on business activities. Details for the call are as follows: Dial in information: Domestic: 1-877-451-6152International: 1-201-389-0879Conference ID: 13746795Webcast Link:https://viavid.webcasts.com/starthere.jsp?ei=1672725&tp_key=f83e7ab481About Cellectis ...
Nasdaq GlobeNewswire
27/05/2024
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X…
Infographic - https://mma.prnewswire.com/media/2422871/Figure_A_Infographic.jpg Infographic -https://mma.prnewswire.com/media/2422871/Figure_A_Infographic.jpg Management Comments Iris Bincovich, the CEO of Innocan commented: "Our LPT-CBD technology has made strong advancements in the past few months. We very much look forward to our upcoming meeting with the FDA in July where they will review and advise on our clinical plan for bringing our LPT-CBD technology to market for...
PR Newswire
27/05/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities…
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – May 27, 2024 – 07:00 PM CET(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on May 24, 2024, from Atlas Special Opportunities, LLC indicating that as of May 22, 2024, it held 2,377,763,043...
Nasdaq GlobeNewswire
27/05/2024
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…
Disclosure of Share Capital and Voting Rights Outstandingas of April 30, 2024(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Charenton-le-Pont, France (May 27, 2024 - 6:00 pm)– As of April 30, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks...
Nasdaq GlobeNewswire
27/05/2024
Personalized Medicine Market Size to Worth USD 152.40 Bn By 2031
The increasing adoption of personalized medicine and growing demand for personalized healthcare are the major factors driving the growth of the personalized medicine market. Personalized medicine considers individual lifestyle, environmental, and genetic differences and helps healthcare providers customize medical treatment accordingly. It is more effective in diagnosing, preventing, and treating diseases in individuals compared to traditional medicine, which follows a…
PR Newswire
27/05/2024
BioSenic S.A. : Positive vote of the majority of creditors in favor of the…
PRESS RELEASE - PRIVILEGED INFORMATIONAfter a recent circular consultation of the creditors, based on XX 83/23 of the Economic Law Code (ELC), the Enterprise Court of Nivelles registers today the positive votes of the majority of creditors on the Restructuration Plan presented by BioSenic and its restructuration practitioner, Maître Yves Brulard. Mont-Saint-Guibert, Belgium, 27 May 2024, 5:00pm CET –BioSenic(Euronext Brussels and Paris: BIOS),the clinical-stage company...
Nasdaq GlobeNewswire
27/05/2024
New "Barbora" CEO - Povilas Šulys
On Tuesday, May 28th, Povilas Šulys will assume the roles of director of UAB "Barbora" and director and board member of its managing company RADAS, UAB. P. Šulys succeeds Viktoras Juozapaitis, who decided to leave the "Vilniaus prekyba" group of companies, where he had been working since 2020. P. Šulys has been working in various group companies since 2016, having led "Franmax," "Ermi group," and "Ermitažas." For the past year and a half, he…
Nasdaq GlobeNewswire
27/05/2024
Altri Comunicati
